A comparison of the cost-effectiveness of almotriptan and sumatriptan in the treatment of acute migraine using a composite efficacy/tolerability end point.

Source:http://linkedlifedata.com/resource/pubmed/id/15228377

Download in:

View as

General Info

PMID
15228377